Excitability properties of mouse motor axons in the mutant SOD1 G93A model of amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 41, Issue 6, 2010, Pages 774-784

  Boërio, Delphine ^a   Kalmar, Bernadett ^a   Greensmith, Linda ^a   Bostock, Hugh ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ALS; Animal model; Axonal depolarization; Motor neuron; Nerve excitability; Neurodegeneration; SOD1G93A mice; Threshold tracking

Indexed keywords

POTASSIUM; SODIUM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENERGY RESOURCE; FEMALE; HISTOCHEMISTRY; MEMBRANE DEPOLARIZATION; MOTONEURON; MOTOR NERVE; MOUSE; MUSCLE CELL; NERVE EXCITABILITY; NERVE FIBER; NONHUMAN; PERIPHERAL NERVE; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; SCIATIC NERVE; SODIUM CONDUCTANCE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; HUMANS; MICE; MOTOR NEURONS; MUTATION; PERIPHERAL NERVES; POLYMORPHISM, SINGLE NUCLEOTIDE; SUPEROXIDE DISMUTASE; TAIL; TIBIAL NERVE;

EID: 77953048558     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21579     Document Type: Article

References (38)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62. (Pubitemid 23087289)
2. Lambert EH. Electromyography in amyotrophic lateral sclerosis. In Norris FH, Kurland LT, editors. Motor neuron diseases: research on amyotrophic lateral sclerosis and related disorders. New York: Grune and Stratton; 1969. p 135-153.
3. de Carvalho M, Swash M. Fasciculation potentials: a study of amyotrophic lateral sclerosis and other neurogenic disorders. Muscle Nerve 1998;21:336-344. (Pubitemid 28096043)
4. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-158. (Pubitemid 28079733)
5. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000;23:399-409. (Pubitemid 30126986)
6. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002;125:664-675. (Pubitemid 34194419)
7. Kuwabara S, Ogawara K, Sung JY, Mori M, Kanai K, Hattori T, et al. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann Neurol 2002;52:180-187. (Pubitemid 34810598)
8. Nodera H, Bostock H, Kuwabara S, Sakamoto T, Asanuma K, Jia-Ying S, et al. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain 2004;127:203-211. (Pubitemid 38055359)
9. Bostock H, Sharief MK, Reid G, Murray NM. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995;118:217-225.
10. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006;129:953-962.
11. Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006;117:1458-1466. (Pubitemid 43947716)
12. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-1116.
13. Weydt P, Hong SY, Kliot M, Möller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 2003;14:1051-1054. (Pubitemid 36829789)
14. Boërio D, Greensmith L, Bostock H. Excitability properties of motor axons in the maturing mouse. J Peripher Nerv Syst; 2009;14:45-53.
15. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-1775. (Pubitemid 24227760)
16. Kalmar B, Novoselov S, Gray A, Cheetham ME, Margulis B, Green-smith L. Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS. J Neurochem 2008;107:339-350.
17. Yang Q, Kaji R, Hirota N, Kojima Y, Takagi T, Kohara N, et al. Effect of maturation on nerve excitability in an experimental model of threshold electrotonus. Muscle Nerve 2000;23:498-506. (Pubitemid 30164774)
18. George A, Bostock H. Multiple measures of axonal excitability in peripheral sensory nerves: an in vivo rat model. Muscle Nerve 2007;36: 628-636. (Pubitemid 47623850)
19. Moldovan M, Krarup C. Evaluation of Na+/K+ pump function following repetitive activity in mouse peripheral nerve. J Neurosci Methods 2006;155:161-171. (Pubitemid 44232999)
20. Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 2007;55:746-757. (Pubitemid 46663027)
21. Sawai S, Kanai K, Nakata M, Hiraga A, Misawa S, Isose S, et al. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration. Clin Neurophysiol 2008;119:1097-1105.
22. Kieran D, Greensmith L. Inhibition of calpains, by treatment with leupeptin, improves motorneuron survival and muscle function in models of motoneuron degeneration. Neuroscience 2004;125:427-439. (Pubitemid 38446748)
23. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000;123:2542-2551.
24. Tan SV, Lee PJ, Walters RJ, Mehta A, Bostock H. Evidence for motor axon depolarization in Fabry disease. Muscle Nerve 2005;32:548-551. (Pubitemid 41395991)
25. LaMonte BH, Wallace KE, Holloway BA, Shelly SS, Ascaño J, Tokito M, et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002;34:715-727. (Pubitemid 34628735)
26. Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD. J Neurosci 1996;18:3241-3250. (Pubitemid 28186017)
27. De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF, et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 2007;16:2720-2728. (Pubitemid 350018514)
28. Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 2005;32:43-50. (Pubitemid 40917888)
29. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004;185:232-240. (Pubitemid 38084849)
30. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 2000;20:2534-2542. (Pubitemid 30220340)
31. Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 2006;9:408-419. (Pubitemid 43290971)
32. Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2007;28:154-164. (Pubitemid 47615455)
33. Vucic S, Kiernan MC. Upregulation of persistent sodium conductance in familial ALS. J Neurol Neurosurg Psychiatry [Epub 2009 Sep 2].
34. Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008;131:1540-1550. (Pubitemid 351806458)
35. Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K, Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003;126:965-973. (Pubitemid 36372993)
36. + currents in human neuropathy and motor neuron disease estimated by latent addition. Clin Neurophysiol 2006;117:2451-2458.
37. Nakata M, Baba H, Kanai K, Hoshi T, Sawai S, Hattori T, et al. Changes in Na(+) channel expression and nodal persistent Na(+) currents associated with peripheral nerve regeneration in mice. Muscle Nerve 2008;37:721-730. (Pubitemid 351821899)
38. Moldovan M, Alvarez S, Krarup C. Motor axon excitability during Wallerian degeneration. Brain 2009;132:511-523.